Presented for research literature review only Okai M et al
PwCs consumer research of roughly 3,000 people found that GLP-1 users spent about 11% less on most food categories overall, and at the scale of adoption now underway, those individual household changes aggregate into the revenue reduction JPMorgan estimates at between $30 billion and $55 billion for the food and beverage industry by 2030 to 2034
But for most people, the real concern isnt about becoming whiter its about addressing dark spots, hyperpigmentation, and uneven skin tone
Noom first introduced its Microdose GLP-1 Program in August for people with a BMI of 25 or higher
Burke LK, Ogunnowo-Bada E, Georgescu T, Cristiano C, de Morentin PBM, Valencia Torres L, et al
3094) was created in February 2024 and is about gastrointestinal complications (e.g., ileus, pancreatitis, and gastroparesis) that the drug allegedly caused